SCWorx (NASDAQ:WORX – Get Free Report) and Materialise (NASDAQ:MTLS – Get Free Report) are both computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability and institutional ownership.
Insider & Institutional Ownership
1.9% of SCWorx shares are owned by institutional investors. Comparatively, 19.3% of Materialise shares are owned by institutional investors. 2.9% of SCWorx shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Earnings and Valuation
This table compares SCWorx and Materialise”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| SCWorx | $2.99 million | 0.84 | -$1.14 million | ($1.07) | -0.30 |
| Materialise | $288.70 million | N/A | $14.54 million | $0.10 | 57.00 |
Materialise has higher revenue and earnings than SCWorx. SCWorx is trading at a lower price-to-earnings ratio than Materialise, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of recent recommendations for SCWorx and Materialise, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| SCWorx | 1 | 0 | 0 | 0 | 1.00 |
| Materialise | 1 | 0 | 0 | 0 | 1.00 |
Profitability
This table compares SCWorx and Materialise’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| SCWorx | -105.74% | -58.42% | -43.85% |
| Materialise | 2.08% | 2.25% | 1.41% |
Risk & Volatility
SCWorx has a beta of 2.6, meaning that its share price is 160% more volatile than the S&P 500. Comparatively, Materialise has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500.
Summary
Materialise beats SCWorx on 8 of the 10 factors compared between the two stocks.
About SCWorx
SCWorx Corp. develops and markets health care information technology solutions and related services to improve healthcare processes and information flow within hospitals and other healthcare facilities in the United States. The company provides data content and services related to repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. It also offers virtualized item master file repair, expansion, and automation; electronic medical record management; charge description master management; contract management; request for proposal automation; rebate management; integration of acquired management; big data analytics modeling; data integration and warehousing; and ScanWorx. In addition, the company focuses on selling personal protective equipment and COVID-19 rapid test kits. It sells its solutions and services to hospitals and health systems through its direct sales force, and distribution and reseller partnerships. SCWorx Corp. is based in New York, New York.
About Materialise
Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
Receive News & Ratings for SCWorx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SCWorx and related companies with MarketBeat.com's FREE daily email newsletter.
